Mary Mosher

Array ( [id] => 5330217 [patent_doc_number] => 20090110694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Anti-Inflammatory Proteins and Improved Vaccines' [patent_app_type] => utility [patent_app_number] => 12/225456 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18619 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110694.pdf [firstpage_image] =>[orig_patent_app_number] => 12225456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379318 [patent_doc_number] => 20090191157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'USE OF RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOR THE TREATMENT OF TYPE 1 HYPERSENSITIVITY IN A LIVING ANIMAL INCLUDING HUMANS' [patent_app_type] => utility [patent_app_number] => 12/282975 [patent_app_country] => US [patent_app_date] => 2007-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11590 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191157.pdf [firstpage_image] =>[orig_patent_app_number] => 12282975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32561 [patent_doc_number] => 07785603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Influenza virus vaccine composition and methods of use' [patent_app_type] => utility [patent_app_number] => 11/715973 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 59783 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785603.pdf [firstpage_image] =>[orig_patent_app_number] => 11715973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224716 [patent_doc_number] => 20070253982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Compositions that include hemagglutinin, methods of making and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/714873 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 88086 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253982.pdf [firstpage_image] =>[orig_patent_app_number] => 11714873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467201 [patent_doc_number] => 20100040606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections' [patent_app_type] => utility [patent_app_number] => 11/792927 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31518 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040606.pdf [firstpage_image] =>[orig_patent_app_number] => 11792927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101282 [patent_doc_number] => 20070184544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Culturing circular ssDNA viruses for the production of vaccines' [patent_app_type] => utility [patent_app_number] => 11/680420 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13677 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184544.pdf [firstpage_image] =>[orig_patent_app_number] => 11680420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464444 [patent_doc_number] => 20090324644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/280568 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8281 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324644.pdf [firstpage_image] =>[orig_patent_app_number] => 12280568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5130733 [patent_doc_number] => 20070207130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Stem cell therapy to treat symptoms of avian flu and other diseases' [patent_app_type] => utility [patent_app_number] => 11/712535 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3307 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207130.pdf [firstpage_image] =>[orig_patent_app_number] => 11712535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246936 [patent_doc_number] => 20070243170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Targeting of Herpes Simplex Virus to Specific Receptors' [patent_app_type] => utility [patent_app_number] => 11/677026 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27045 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243170.pdf [firstpage_image] =>[orig_patent_app_number] => 11677026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488813 [patent_doc_number] => 08029796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Therapeutic anti-cytomegalovirus compounds' [patent_app_type] => utility [patent_app_number] => 11/707321 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19126 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029796.pdf [firstpage_image] =>[orig_patent_app_number] => 11707321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 266933 [patent_doc_number] => 07566457 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Chimeric proteins that induce effects directed against viruses' [patent_app_type] => utility [patent_app_number] => 11/705696 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20780 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566457.pdf [firstpage_image] =>[orig_patent_app_number] => 11705696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299570 [patent_doc_number] => 07537768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Influenza virus vaccine composition and methods of use' [patent_app_type] => utility [patent_app_number] => 11/704251 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 60157 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537768.pdf [firstpage_image] =>[orig_patent_app_number] => 11704251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177495 [patent_doc_number] => 20070178555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS' [patent_app_type] => utility [patent_app_number] => 11/700899 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 31283 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178555.pdf [firstpage_image] =>[orig_patent_app_number] => 11700899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151841 [patent_doc_number] => 07678774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Treating severe acute respiratory syndrome' [patent_app_type] => utility [patent_app_number] => 11/698038 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2866 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678774.pdf [firstpage_image] =>[orig_patent_app_number] => 11698038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32565 [patent_doc_number] => 07785604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Attenuated flavivirus strains containing a mutated M-ectodomain and their applications' [patent_app_type] => utility [patent_app_number] => 11/614414 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9515 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785604.pdf [firstpage_image] =>[orig_patent_app_number] => 11614414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6558196 [patent_doc_number] => 20100233674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Cells for detection and production of influenza and parainfluenza viruses' [patent_app_type] => utility [patent_app_number] => 11/642131 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13733 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233674.pdf [firstpage_image] =>[orig_patent_app_number] => 11642131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068964 [patent_doc_number] => 20070190065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein' [patent_app_type] => utility [patent_app_number] => 11/635822 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11159 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190065.pdf [firstpage_image] =>[orig_patent_app_number] => 11635822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284 [patent_doc_number] => 07811805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Mutant paramyxovirus and method for production thereof' [patent_app_type] => utility [patent_app_number] => 12/085355 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 18693 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811805.pdf [firstpage_image] =>[orig_patent_app_number] => 12085355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284 [patent_doc_number] => 07811805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Mutant paramyxovirus and method for production thereof' [patent_app_type] => utility [patent_app_number] => 12/085355 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 18693 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811805.pdf [firstpage_image] =>[orig_patent_app_number] => 12085355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284 [patent_doc_number] => 07811805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Mutant paramyxovirus and method for production thereof' [patent_app_type] => utility [patent_app_number] => 12/085355 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 18693 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811805.pdf [firstpage_image] =>[orig_patent_app_number] => 12085355 [rel_patent_id] =>[rel_patent_doc_number] =>)